Research output per year
Research output per year
Personal profile
Research interests
My primary clinical research focus is the implementation of novel analytical methodologies to improve treatment decision-making in patients with cancer.
Clinical interests
Immunotherapy clinical trials, primary brain tumors and brain metastases, melanoma, merkel cell carcinoma.
Available to Mentor:
- PhD/MSTP Students
Fingerprint
Dive into the research topics where Tanner Johanns is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A pilot study of lymphoscintigraphy with tracer injection into the human brain
Coxon, A. T., Desai, R., Patel, P. R., Vellimana, A. K., Willie, J. T., Dowling, J. L., Leuthardt, E. C., Kim, A. H., Johanns, T. M., Siegel, B. A. & Dunn, G. P., 2023, (Accepted/In press) In: Journal of Cerebral Blood Flow and Metabolism.Research output: Contribution to journal › Article › peer-review
-
Computational prediction of MHC anchor locations guides neoantigen identification and prioritization
Xia, H., McMichael, J., Becker-Hapak, M., Onyeador, O. C., Buchli, R., McClain, E., Pence, P., Supabphol, S., Richters, M. M., Basu, A., Ramirez, C. A., Puig-Saus, C., Cotto, K. C., Freshour, S. L., Hundal, J., Kiwala, S., Goedegebuure, S. P., Johanns, T. M., Dunn, G. P., Ribas, A., & 5 others, Apr 2023, In: Science immunology. 8, 82, eabg2200.Research output: Contribution to journal › Article › peer-review
-
Erratum: Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget)
Khaddour, K., Dowling, J., Huang, J., Council, M., Chen, D., Cornelius, L., Johanns, T., Dahiya, S. & Ansstas, G., Feb 11 2023, In: Oncotarget. 14, p. 126 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma
Schaettler, M. O., Desai, R., Wang, A. Z., Livingstone, A. J., Kobayashi, D. K., Coxon, A. T., Bowman-Kirigin, J. A., Liu, C. J., Li, M., Bender, D. E., White, M. J., Kranz, D. M., Johanns, T. M. & Dunn, G. P., Feb 20 2023, In: Journal for ImmunoTherapy of Cancer. 11, 2, e006121.Research output: Contribution to journal › Article › peer-review
Open Access -
The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain
Bowman-Kirigin, J. A., Desai, R., Saunders, B. T., Wang, A. Z., Schaettler, M. O., Liu, C. J., Livingstone, A. J., Kobayashi, D. K., Durai, V., Kretzer, N. M., Zipfel, G. J., Leuthardt, E. C., Osbun, J. W., Chicoine, M. R., Kim, A. H., Murphy, K. M., Johanns, T. M., Zinselmeyer, B. H. & Dunn, G. P., Jan 3 2023, In: Cancer immunology research. 11, 1, p. 20-37 18 p.Research output: Contribution to journal › Article › peer-review